Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 31, 2015 6:52 PM ET

Biotechnology

Company Overview of CareDx, Inc

Company Overview

CareDx, Inc, a commercial stage company, develops, markets, and delivers diagnostic surveillance solutions for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime. Its commercialized testing solution includes the AlloMap heart transplant molecular test (AlloMap), a blood-based test used to monitor heart transplant recipients for acute cellular rejection. The company markets its AlloMap solution to healthcare providers through its direct sales force that targets transplant centers and their physicians, coordinators, and nurse practitioners in the United States, Canada, and Europe. The company was formerly known as XDx...

3260 Bayshore Boulevard

Brisbane, CA 94005

United States

Founded in 1998

68 Employees

Phone:

415-287-2300

Fax:

415-287-2450

Key Executives for CareDx, Inc

Chief Executive Officer, President and Director
Age: 48
Total Annual Compensation: $547.6K
Chief Medical Officer and Executive Vice President
Age: 66
Total Annual Compensation: $524.5K
Chief Compliance Officer and Chief Business Officer
Age: 45
Total Annual Compensation: $445.5K
Compensation as of Fiscal Year 2014.

CareDx, Inc Key Developments

CareDx, Inc Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 04:30 PM

CareDx, Inc Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 04:30 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Kenneth E. Ludlum, Chief Financial Officer, Peter Maag, Chief Executive Officer, President and Director.

CareDx, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015; Confirms Earnings Guidance for the Full Year of 2015

CareDx Inc. announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenue of $7,216,000 against $5,924,000 a year ago. Loss from operations was $1,391,000 against $227,000 a year ago. Net loss was $2,272,000 against $1,304,000 a year ago. Basic and diluted net loss per share was $0.19 against $1.29 a year ago. The company confirmed revenue for the full year of 2015 is expected to be in the range of $28 to $30 million.

CareDx, Inc Presents at JMP Securities Life Sciences Conference, Jun-23-2015 03:30 PM

CareDx, Inc Presents at JMP Securities Life Sciences Conference, Jun-23-2015 03:30 PM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States. Speakers: Kenneth E. Ludlum, Chief Financial Officer, Peter Maag, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Axygen Biosciences, Inc. United States
Athenix Corp. United States
Counterpoint Health Solutions, Inc. United States
Tranzderm Solutions United States
C2 Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
January 30, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CareDx, Inc, please visit www.caredx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.